This Article Full Text Full Text (PDF) All Versions of this Article: 22/7/1129    most recent 01.ATV.0000022600.61391.A5v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by von Bahr, S. Articles by Björkhem, I. Search for Related Content PubMed PubMed Citation Articles by von Bahr, S. Articles by Björkhem, I. Related Collections Cell biology/structural biology Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:1129.)
© 2002 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Mechanism of Accumulation of Cholesterol and Cholestanol in Tendons and the Role of Sterol 27-hydroxylase (CYP27A1)

Sara von Bahr; Tomas Movin; Nikos Papadogiannakis; Irina Pikuleva; Per Rönnow; Ulf Diczfalusy; Ingemar Björkhem

From the Divisions of Clinical Chemistry (S.v.B., U.D., I.B.), Orthopedics (T.M.), Pathology (N.P.), and Lung Medicine (P.R.), Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden; and Department of Pharmacology and Toxicology (I.P.), University of Texas Medical Branch, Galvestone, Tex.

Correspondence to Ingemar Björkhem, Division of Clinical Chemistry, Karolinska Institutet, Huddinge University Hospital, SE-141 86 Stockholm. E-mail Ingemar.Bjorkhem{at}chemlab.hs.sll.se

Objective— Tendon xanthomas are deposits of lipids and connective tissue commonly found in hypercholesterolemic patients. Macrophages are likely to be responsible for the lipid accumulation. Normolipidemic patients with the rare disease cerebrotendinous xanthomatosis, lacking the enzyme sterol 27-hydroxylase (CYP27A1), develop prominent xanthomas in tendons and brain containing both cholestanol and cholesterol, with a cholestanol:cholesterol ratio higher than that in the circulation. Because of its ability to convert cholesterol into polar metabolites that leave the cells faster, CYP27A1 has been suggested to be an antiatherogenic enzyme. The hypothesis was tested that tendons contain CYP27A1 that may be of importance for the normal efflux of both steroids.

Methods and Results— Western blotting and combined gas chromatography-mass spectrometry showed that human tendons contain significant amounts of CYP27A1 and its product, 27-hydroxycholesterol. Immunohistochemistry showed that CYP27A1 is present in macrophages and tenocytes. The tendons also contained cholestanol, with a cholestanol:cholesterol ratio slightly higher than that in the circulation. Recombinant human CYP27A1, and cultured human macrophages containing this enzyme, had similar activity toward cholesterol and cholestanol. After loading of macrophages with labeled cholesterol and cholestanol, there was an efflux of these steroids in both unmetabolized and 27-oxygenated form, resulting in a significant cellular accumulation of cholestanol compared with cholesterol.

Conclusion— The results are consistent with the possibility that CYP27A1 is of importance for the efflux of both cholesterol and cholestanol from tendons.

Key Words: tendon xanthomas • cerebrotendinous xanthomatosis • atherosclerosis • sterol transport

This article has been cited by other articles:

				U. Panzenboeck, U. Andersson, M. Hansson, W. Sattler, S. Meaney, and I. Bjorkhem On the mechanism of cerebral accumulation of cholestanol in patients with cerebrotendinous xanthomatosis J. Lipid Res., May 1, 2007; 48(5): 1167 - 1174. [Abstract] [Full Text] [PDF]

				G. Escher, A. Hoang, S. Georges, U. Tchoua, A. El-Osta, Z. Krozowski, and D. Sviridov Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages J. Lipid Res., February 1, 2005; 46(2): 356 - 365. [Abstract] [Full Text] [PDF]

				M. Norlin, S. von Bahr, I. Bjorkhem, and K. Wikvall On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation J. Lipid Res., August 1, 2003; 44(8): 1515 - 1522. [Abstract] [Full Text] [PDF]

				G. Escher, Z. Krozowski, K. D. Croft, and D. Sviridov Expression of Sterol 27-Hydroxylase (CYP27A1) Enhances Cholesterol Efflux J. Biol. Chem., March 21, 2003; 278(13): 11015 - 11019. [Abstract] [Full Text] [PDF]